President Trump Issues Executive Order to Reschedule Marijuana: A Turning Point for Cannabis and Hemp Industries
— December 18, 2025 In a historic move, President Trump has signed an executive order directing the Department of Justice and the Drug Enforcement Administration to reclassify marijuana from Schedule I to Schedule III under the Controlled Substances Act. This action, effective immediately, marks the most significant federal shift in cannabis policy in decades. For the hemp and marijuana industries, this is more than symbolic. It opens pathways for legitimate business deductions, banking access, and expanded medical research. While state laws remain in place, the federal government’s recognition of marijuana as a regulated substance rather than a prohibited one changes the landscape overnight.
Inspirational Technologies Statement
“Since 2014, Inspirational Technologies and PAiNT Network have advocated for reform that empowers communities, farmers, and innovators. Today’s executive action is a watershed moment. Hemp and marijuana are no longer trapped in the shadows of prohibition — they are recognized as industries with legitimate economic and health potential. We stand ready to help stakeholders navigate this new era with clarity, compliance, and opportunity.” — Steven Smith, Owner since 2014
What Hemp and Marijuana Industries Should Do Right Now
Reassess Financial Strategy
With Schedule III status, cannabis businesses may now claim ordinary business deductions. Operators should immediately consult tax professionals to restructure filings and maximize profitability.
Strengthen Banking Relationships
Begin conversations with local and regional banks. Federal reclassification reduces risk for financial institutions, opening doors to loans, credit lines, and merchant services.
Prepare for Interstate Opportunities
While interstate transport remains subject to state laws, today’s action signals eventual harmonization. Companies should map potential supply chains and partnerships across state borders.
Invest in Compliance and Research
Schedule III status allows expanded medical research. Businesses should consider partnerships with universities, labs, and pharmaceutical firms to position themselves at the forefront of innovation.
Monitor State Responses
States will adapt differently. Some may accelerate legalization and regulation, while others may tighten controls. Businesses must stay agile and ready to adjust strategies to local frameworks.
Looking Ahead to 2026
By 2026, the cannabis and hemp industries could see:
Normalized taxation and accounting practices
Expanded interstate commerce frameworks
Mainstream institutional investment
Accelerated medical research and product development
Inspirational Technologies and PAiNT Network will continue to provide Code Green advocacy, compliance checklists, and accessible guides to ensure that farmers, entrepreneurs, and communities thrive in this new regulatory environment.
Bottom Line: The executive order is not the end of the journey — it is the beginning of a new chapter. Hemp and marijuana industries must act decisively, strategically, and responsibly to seize the opportunities created today.
Renovation of the American Dream – Inspirational Technologies
Code Green Compliance Checklist:
What Cannabis and Hemp Businesses Must Do Immediately
Inspirational Technologies / PAiNT Network — December 15, 2025 With President Trump’s executive order reclassifying marijuana to Schedule III, the cannabis and hemp industries face a new regulatory reality. This is a moment to act decisively. Below is our Code Green Compliance Checklist — practical steps every operator should take right now to align with federal changes and prepare for 2026 growth.
✅ Financial & Tax Readiness
Recalculate tax obligations: Schedule III status allows ordinary business deductions. Meet with accountants immediately to restructure filings.
Update cash flow models: Factor in reduced tax burdens and potential new financing options.
Document compliance costs: Track expenses for licensing, testing, and reporting to maximize deductions.
✅ Banking & Capital Access
Engage local banks: Begin conversations with institutions now that federal risk is reduced.
Prepare credit packages: Assemble financial statements, compliance records, and growth plans to secure loans.
Explore institutional partnerships: Position your company for venture capital or private equity interest.
✅ Interstate Transport & Logistics
Map supply chains: Identify states with compatible regulations for potential cross-border partnerships.
Review insurance policies: Ensure cargo and liability coverage reflects new federal risk profiles.
Pilot compliant routes: Test small-scale interstate shipments where both states allow.
Comply Bag Technology
✅ Compliance & Research Expansion
Strengthen compliance teams: Build capacity to track evolving state and federal rules.
Partner with universities: Explore joint research ventures now that barriers to clinical studies are reduced.
Invest in product innovation: Prepare for FDA pathways for cannabis-derived medicines.
✅ State-Level Monitoring
Track state responses: Some states will liberalize quickly, others may tighten controls.
Adjust licensing strategies: Be ready to expand or contract operations based on local frameworks.
Engage policymakers: Advocate for harmonization to reduce friction in interstate commerce.
Inspirational Technologies Statement
“This is Code Green in action. The executive order is not just a policy shift — it’s a call to readiness. Hemp and marijuana industries must move from survival mode to strategic growth. Compliance, banking, and interstate logistics are the pillars of success in this new era.” — Steven Smith, Owner since 2014
2026 Outlook
By 2026, operators who act now will be positioned to:
Enjoy normalized taxation and profitability
Access mainstream banking and capital markets
Expand across state lines with compliant logistics
Lead in medical research and product development
Bottom Line: The executive order is history in the making. The winners will be those who treat this as a multi-year compliance and growth strategy — not a short-term rally. Code Green means acting today to secure tomorrow.
Predictive Artificial Intelligence News & Technology1st Hemp USA News is a resource of Inspirational Technologies (2021)Logo by Steven M Smith Created 3/1/2014
New Hampshire Governor Chris Sununu (R) recently signed into law a significant expansion of the state’s medical marijuana program, a move that broadens access to cannabis for patients with a wide range of conditions.
This new legislation, HB 1278, marks a major shift from previous restrictions, which limited eligibility to specific, enumerated conditions, reported Marijuana Moment.
Broadening Access: What New Law Means For Medical Marijuana Patients
The new law significantly alters the landscape of medical marijuana use in New Hampshire. Under HB 1278, doctors can now recommend cannabis for “any debilitating or terminal medical condition or symptom for which the potential benefits of using therapeutic cannabis would, in the provider’s clinical opinion, likely outweigh the potential health risks for the patient.”
This provision is set to replace the previous, more restrictive list of qualifying conditions, allowing for greater flexibility in patient care.
This broader eligibility could potentially address a range of conditions previously overlooked, such as severe menstrual cramps, symptoms of long COVID and anxiety related to dental procedures or post-surgical pain control.
Recent Legislative Changes In NH
The enactment of HB 1278 follows two other recent legislative changes signed by Sununu that also expand the medical marijuana program.
One of these bills adds generalized anxiety disorder as a qualifying condition, while another broadens the pool of healthcare providers who can certify patients for the program.
However, not all of Sununu’s recent decisions regarding medical marijuana have been supportive. Last month, he vetoed a bill that would have allowed medical marijuana businesses to open additional cultivation locations, including greenhouses. Sununu’s veto statement criticized the bill for lacking sufficient detail on safety, security, and location requirements.
I hope this information was helpful and informative. If you have any more questions, please feel free to ask me. 😊
Inspirational Technologies – IT is Time
We, at Inspirational Technologies are at the forefront of Inspirational and Frontrunners on the frontier of current technology.
We are often faced with our own personal conflicts which directly influence our interactions with our peers and family.
When Inspirational Technologies is an endorsement of the “Cannabis” approach to the medical condition, we say, let’s let the look at the data and the people who say that they benefit for cannabis alternatives.
Steven M Smith InspirationalTech.org CEO since 2013.
LAS VEGAS, NV – Romaine calm! Hemp, Inc. is to report that the global hemp-based foods market is showing strong indicators of growth, fueled by the rising vegan population, advancements in processing technology, and the increasing number of health-conscious consumers seeking plant-based and gluten-free alternatives. The hemp-based foods market is set to reach $8.36 billion by 2028 according to The Business Research Company’s (TBRC) latest report, “Hemp Based Foods Global Market Report 2024″. The report unveils a comprehensive overview of the hemp-based foods sector. Projected to achieve a robust compound annual growth rate (CAGR) of 8.9%, the market is anticipated to burgeon from its current standing to an impressive $8.36 billion by 2028. This surge is attributed primarily to the expanding vegan population across the globe. (Great things happen when olive our friends stick together.) Anyway, TBRC’s analysis provides an excellent in-depth look at the hemp-based foods market, breaking it down into critical segments:
— Distribution Channels: Supermarket Stores, Convenience Stores
— Geography: North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East, and Africa
Hemp-based foods, derived from the seeds of the hemp plant, are celebrated for their nutritional completeness, featuring all the essential amino acids required by the human body. The report highlights hemp milk, hemp oil, hemp cheese substitutes, and hemp-based protein powders as key products fueling the market’s growth. Notably, hemp seed oil emerges as a versatile product, finding utility in both culinary applications and as a valued ingredient in cosmetic formulations.
The report underscores the diverse uses of hemp seeds and oils, highlighting their nutritional profile rich in omega fatty acids and gamma-linolenic acid. Their therapeutic properties, bolstered by high antioxidant content, make hemp-based foods an attractive option for health-conscious consumers.
Distributed primarily through supermarkets and convenience stores, hemp-based foods are becoming increasingly accessible to consumers worldwide, further propelling market growth. And with a robust infrastructure for hemp cultivation and a steadily growing demand for plant-based food from our vegan slayers here, North America is poised to dominate the market share, according to the Report. Yes, the forks have spoken and Hemp, Inc. is one of the companies at the forefront listening!
Hemp, Inc. has been one of the key players in this burgeoning industry, driving the market forward with its quality products and strategic market approaches. Coupled with an invaluable roster of connections with hemp manufacturers and vendors across the country and abroad, the Company expects to see meteoric growth curves on a domestic and international scale as the industry continues to grow.
Through its e-portal (www.hempinc.com), the Company’s hemp-derived products are poised to capture a large share of the marketplace on a global scale and to play a vital role in maintaining good health and well-being… two significant growth factors of the CBD market. The Company’s product line contains CBD, CBDA, CBG, CBGA, and CBN (non-psychoactive compounds found in cannabis plants). These are active ingredients in cannabis that are derived from the hemp plant, which is widely known for pain relief, relaxation, and anxiety relief. A recipe is only as good as its ingredients and how those ingredients are blended.
Hemp, Inc. is the only company in America that uses pharmaceutical-grade beta-cyclodextrin (a carbohydrate used during the manufacturing process). Carbohydrates bond with oils including all the cannabinoids for massive and rapid absorption and uptake. The Company’s CBD, CBDA, CBG, CBGA, and CBN product lines are highly potent therapeutic doses that have received rave reviews.
Hemp, Inc. has also pushed the boundaries with its CBD/CBG coffee enhancer. This powerhouse product is super potent, absorbs rapidly in coffee, and is 4 times more potent (at a fraction of the price) than other hemp-derived coffee enhancers currently on the market. Its high-quality ingredient combination offers 30 servings per bottle and contains a total of 10,000mg of cannabinoids (7,500mg CBD and 2,500mg CBG) in an MCT oil base. Per serving, that’s 250mg CBD and 83mg CBG remarkably mixed in a wonderfully rich cup of coffee.
The CBD/CBG coffee enhancer comes in plain (natural) and vanilla flavors. The plain (natural) coffee enhancer is available now and the vanilla flavor will be available by the end of this month. A single container (7-day supply) retails for $27.95 and a bottle (30-day supply) retails for $99.95. Wholesale bulk orders are single-use packages, available through select restaurants. Currently, Hemp, Inc. has decided to expand its product line and has updated its website. The Company will announce its new products as they are launched throughout the year.
Hemp, Inc. also discovered its grounded kenaf and hemp blend is the perfect substrate to grow healthy and/or medicinal mushrooms and can make and/or provide the raw materials to produce hemp-based products such as hempcrete, horse bedding, hemp bio-plastics, and more. As one of the most rapidly growing plants on the planet, the hemp plant is used to make a variety of hemp products. It can be shifted into rope, paper, textiles, clothing, disposable polymers, paint, insulation, food, and animal feed.
On the industrial side, Hemp, Inc.’s industrial hemp plant in North Carolina manufactures and sells two industrial hemp products: Spill-Be-Gone(TM) (an oil spill cleanup product made from the core particles and powder of the kenaf and hemp plant) and DrillWall(TM) (a non-toxic, biodegradable drilling fluid additive used in oilfield drilling applications). Hemp, Inc.’s Spill-Be-Gone(TM) is sold in industrial-sized quantities for large oil spill cleanups. It is fast and cost-effective in cleaning up oil spills on land or water. The Company’s DrillWall(TM) is a tested LCM made of kenaf and hemp cellulose. It includes milled products from kenaf and hemp that are made into oil drilling fluid additives and oil absorbents.
What Cannabis Can (and Can’t) do for Chronic Pain. Pot for Pain Relief?
(Story by Karen Weintraub, USA TODAY) reprinted 1/26/2023.
A growing, but still incomplete body of research suggests the cannabis plant, the source of marijuana, can help fight some kinds of pain.
Rob Sims grew up hearing stories about what opioid addiction could do. The former Detroit Lions guard, whose father, Mickey, also played in the NFL, watched a number of his dad’s friends get hooked. Some died. He vowed his own story would be different.
Then, playing for the Seattle Seahawks in 2008, early in his pro football career, Sims tore a pectoralis muscle in his chest. Primed for his best year ever, Sims was sidelined.
After surgery, he received an open-ended prescription for opioids. “Take when you have pain,” the bottle read. “That’s seared in my memory,” he said. As a football player, “I have pain all the time.”
Scared by the lesson he had learned as a child and with little to do besides focus on his recovery, he remembers thinking: “This could go in a bad way.”
That’s when he turned to marijuana.
It remains unclear whether cannabis can be an effective treatment for pain. Plenty of circumstantial evidence supports the idea, but exactly how, what kinds of products and what can be expected from them has yet to be determined.
“There’s some caveats before it’s ready for broad, prime-time usage for chronic pain,” said Dr. Devan Kansagara, a professor of medicine at Oregon Health & Science University and a staff physician at the VA Portland.
It’s possible that cannabis helps with the psychological aspects of pain, said Dr. Nora Volkow, head of the National Institute on Drug Abuse. “Cannabis may improve pain indirectly, for instance, through decreasing anxiety so that someone may be able to deal with pain better,” she said.
One recent examination of previous studies found the benefits of cannabis were equal to the benefits of a placebo, which means that if people thought it would help, it did.
“There’s very limited evidence out there to support that cannabis is effective against pain,” said Karin Jensen, the Swedish neuroscientist who led the study. So far, most of the information showing its usefulness is anecdotal.
“People who use cannabis to relieve pain may have the experience that it helps – there is no doubt about that,” she said. “What’s needed is solid scientific evidence to determine how much of the relief is due to the cannabis and how much is due to other things, such as the placebo effect.”
The general public is already largely convinced.
Marijuana remains illegal in 12 states, but as of 2019, 18% of U.S. adults reported using cannabis at least once in the previous year, and 4% to 5% use it daily or nearly daily, Kansagara said.
It’s not possible to predict ahead of time who will react badly to marijuana, said Dr. Charles Berde, co-founder of a pediatric pain clinic at Boston Children’s Hospital.
THC, the part of the plant that has psychotropic effects, “has narrow uses for nausea and appetite stimulation in patients with severe weight loss due to AIDS or cancer,” but the data for CBD for treatment of chronic pain is “murky,” Berde said. “All the more reason to be hesitant to prescribe it.”
Cannabis and pain relief
When a body is in pain, the brain releases its own pain relievers. There are special receptors in the brain designed to take in these natural cannabinoids and offer relief.
Ingesting or inhaling weed fills up those receptors, too.
Providing more cannabinoids than these receptors can accept overloads them making the person’s own internal cannabinoids ineffective, said Dr. Jordan Tishler, a cannabis specialist physician in Cambridge, Massachusetts, and founder and president of the Association of Cannabinoid Specialists.
That’s why higher doses don’t provide any additional pain relief compared with lower ones and can have “all sorts of risks,” he said. Side effects from cannabis can include increased heart rate, dizziness, impaired concentration and memory, slower reaction times and, more rarely, increased risk of heart attack and stroke and dependence.
Tishler said many patients come to him taking far too much cannabis, which increases the risk for side effects. He works to convince them that 5 mg to 20 mg a day will treat their pain better than the 200 mg they’re using.
Cannabis is now sold in many different forms.
“Just because (cannabis) doesn’t lead to breaking the law and incarceration and those sorts of troubles doesn’t mean people can’t have their lives significantly altered by getting overly involved with this particular substance,” he said.
There are also open questions about cannabis, including whether the pain-killing benefits seen in short-term studies will last. Some painkillers, like opioids, can actually make people more sensitive to pain. It’s not yet clear whether cannabis can have this effect.
“You’d like to see what happens with these products over a longer period of time, ideally,” Kansagara said. “I would like to see that before recommending wholesale to patients.”
Although legalization and decriminalization are making a difference, cannabis remains hard to study. Until recent years, it was extremely difficult to gain access to cannabis for research, and there was little federal funding for such work. In early December, President Joe Biden signed a law that will make it easier to research cannabis.
Gold-standard studies compare a treatment versus a placebo, but it’s impossible to keep people in the dark about whether they’re getting high, said Dr. Donald Abrams, an oncologist and professor emeritus at University of California, San Francisco, who studies cannabis.
When Abrams studied cannabis use in his HIV patients, some critics thought patients must be too stoned to notice their pain. But Abrams said the patients reported that it did alleviate their pain.
Dosages of cannabis aren’t standardized, which adds to the difficulty of comparing one study against another, he said.
That’s why trials of cannabis for pain relief have shown mixed results, said Wil Ngwa, an associate professor of radiation oncology at Johns Hopkins Medicine, who’s working to create such standards for drug trials.
This lack of standardization also means people have to use trial and error to find an effective dose for them, according to Staci Gruber, who directs the Marijuana Investigations for Neuroscientific Discovery (MIND) program at McLean Hospital, a Harvard-affiliated psychiatric hospital outside Boston.
In one study, Gruber followed 37 volunteers using cannabis for chronic pain. After six months of treatment, participants reported lower levels of pain, better sleep, more coherence and less use of conventional painkillers.
‘Positives, not negatives’
Sims experienced the same benefits.
Daily marijuana use after his pec injury helped cut the pain, allowing him to lift more weight and recover faster. “I was able to come back stronger than I was before.”
Playing NFL ball, Sims said, is like living through a train wreck every Sunday. The best players – the ones whose careers last the longest, he said – “have learned how to recover quicker and get ready for that next train wreck.”
During his career, marijuana helped Sims rebound and improved his sleep, which allowed him to push his workouts.
Asked about side effects from his marijuana use, Sims pointed to his athletic and financial successes. “I wouldn’t call those side effects,” he said, laughing. “I see positives, not negatives.”
In 2021, Sims co-founded the cannabis company Primitiv Group with fellow former Lion Calvin Johnson Jr. Sims and Johnson acknowledge they used cannabis during their professional careers, though there was a zero tolerance policy then, which has loosened only slightly since. Both men believe the restrictions should be lifted.
About a decade ago, Sims persuaded his wife, Natalie, to try cannabis, when a bout with the bowel syndrome Crohn’s disease left her on a morphine drip in an emergency room.
“This can’t be how we live for the rest of our lives,” he told her. She uses cannabis now and finds relief, Sims said.
“It made me very passionate about pain and help for pain.”
Challenges of cannabis care
Cannabis doesn’t make pain go away, like Advil might get rid of a headache, Tishler said.
Instead, “it makes it so it doesn’t bother you so much,” he said. “It divorces the pain from the suffering.”
Whether it’s the THC or the CBD in cannabis or both that might be helpful against pain remains an open question, Kansagara said. THC is what makes people feel “high.” CBD appears to have anti-inflammatory properties, which may be useful to some.
Smoking joints isn’t a good approach for relieving chronic pain, said Tishler, who recommends his patients use edibles instead. The effect of inhaled cannabis wears off in three to four hours, while a gummy might last eight to 12 hours.
The yo-yo effect, when pain comes and goes over a few hours, can exacerbate suffering, Tishler said. “Short-acting actually turns out to be a bad approach in general in pain management.”
In Massachusetts, where medical cannabis has been legal since 2013 and recreational since 2016, doctors are more comfortable giving their patients permission to use cannabis, Tishler said. But they rarely bring it up themselves.
So, Tishler is trying to educate his peers. “If you were thinking the patient needs opioids, think cannabis first. Don’t wait for the patient to bring it up – it’s your job to bring it up,” he tells them.
Similarly, he’d like to get cancer patients on cannabis early in their care, rather than waiting until agony sets in. “Once people are at the end of their rope, things are worse and harder to treat than if we had started when things were still kind of OK.”
Most of the advice on what product to use now comes from the patient care advocates or “budtenders” who work behind the counter at dispensaries, Gruber noted with some concern. They typically don’t know the person’s medical history or history of cannabis use or whether they use other substances such as alcohol, other drugs or prescription medication. Product labels can often be misleading about their THC and CBD content.
The trial-and-error approach can be difficult and challenging for patients with major medical problems.
“Knowing what’s in your weed is critical, but also how you’re going to respond to it is an important consideration. And that’s something we don’t spend a lot of time on,” Gruber said. “You have to educate patients. They’re desperate for it, but it’s not easy, because we’re all different and cannabis is not a ‘one size fits all’ solution.”
Research may change future use.
For cannabis to reach its full potential as a painkiller, more research is needed, experts say.
“It’s really untapped right now, because of that lack of research,” Johnson said.
That’s why NFL players and owners have been supporting cannabis research. Owners have donated more than $1 million this year to two cannabis research programs.
“We need to become better educated about all these issues,” said Dr. Allen Sills, the NFL’s chief medical officer.
Ngwa, at Hopkins, collaborates with Sims and Johnson to lead some of that research.
He’s also looking at better ways to treat cancer pain with cannabis.
His studies suggest that not enough of the painkiller gets to a tumor when the cannabis is inhaled or ingested, so he has been exploring smart-drug delivery systems than can target the drug directly to the tumor. So far, he has tested only pancreatic tumors but hopes to rapidly expand to other cancer types.
Ngwa is concerned that preliminary research like his will encourage people to self-medicate, taking doses that may not be helpful. “You really have to wait for the clinical trials, but when people are desperate, they just do (anything). I definitely worry about that,” he said.
Until more is known, Sims will keep up his cannabis routine.
Now 39, he has dropped 50 pounds from his 320-pound playing weight, which has helped reduce the lingering bone-on-bone pain in his right knee. He rubs a Primitiv topical on it knee every day.
“My passion behind the plant and what it’s done for my family reigns supreme.”
Contact Karen Weintraub at kweintraub@usatoday.com.
Health and patient safety coverage at USA TODAY is made possible in part by a grant from the Masimo Foundation for Ethics, Innovation and Competition in Healthcare. The Masimo Foundation does not provide editorial input.
Consuming medicinal cannabis oil improves sleep in adults with insomnia
For More Information on Cannabis and CBD and YOU. Click On the Following Link
1st Hemp USA News is a resource of Inspirational Technologies (2021-2023)Inspirational Technologies (2023) AllRightsReservedYour ONE STOP BLOG FOR INFORMATION, EDUCATION, & INSPIRATION OF ESSENTIAL INNOVATION & RENOVATION of You-THANK YOU FOR YOUR INTEREST*This site receives virtually no compensation for sales of some or all mentioned products. We however place humanitarian value over monetary interests. Our monetary income goes back into research, development, discovery and healing.Inspirational Technologies – is Committed to Your Health Wellness Beauty and EnrichmentReporting on Today’s Internal Botanical and Skin Product Benefits
4 Hemp Club was Inspired by Steven Smith’s vision to
“Have an older generation 4H Club, where an older community of adults could carry on what the younger 4H Club envisioned.
Our 4H Platform Uses HEMP as an Agricultural Focal Point, deserving of research, development and with the
4 Hemp key points being Health Hope and Happiness, thru Hemp“.
Cannabis CBD and Me Inspirational Technologies Inspirational Technologies (2014) @Inspire123tech Background Noise Studios Logos by Steven M Smith
Adults 21 and over can light up in Alaska. In 2015, the northernmost US state made it legal for residents to use, possess, and transport up to an ounce of marijuana — roughly a sandwich bag full — for recreational use. The first pot shop opened for business in 2016.
Alaska has pounced on the opportunity to make its recreational-pot shops a destination for tourists. More than 2 million people visit Alaska annually and spend $2 billion.
Tuesday was a good day for stoners in Maryland and Missouri, as voters approved legalizing recreational marijuana in both places. The two states, which had already legalized medical use, join 19 other states (and D.C.) in making recreational use legal.
In Maryland, there’s a bit of a transitional period (which the Associated Press runs through here). Adult recreational marijuana use will not be legal officially until July 1, 2023, pending the General Assembly passing laws about how to appropriately distribute, regulate, and tax the plant. The Washington Post also notes that effective July 1, adults can grow up “up to two cannabis plants in their home, out of the public view.”
Past marijuana charges in Maryland will also be expunged, thanks to a companion bill passed in the spring that included both a provision to automatically expunge all cases in which possession was the sole charge. It will also allow individuals incarcerated for possession to petition for resentencing. At the time, many local politicians criticized the bill, emphasizing it would do little to nothing to prevent and reduce racial disparities and arrests in marijuana possession.
In other news, Coloradans voted on the decriminalization and regulation of psychedelic mushrooms. It’s still too close to call—with 80 percent of votes counted as of this writing, decriminalization leads 51-49 percent. Colorado would be the second state after Oregon to do so. One could say the state is leaning [looks up the color of magic mushrooms] brown?
1st Hemp USA News is a resource of Inspirational Technologies (2022)Inspirational Technologies (2022) AllRightsReservedYour ONE STOP BLOG FOR INFORMATION, EDUCATION, & INSPIRATION OF ESSENTIAL INNOVATION & RENOVATION of You-THANK YOU FOR YOUR INTEREST*This site receives virtually no compensation for sales of some or all mentioned products. We however place humanitarian value over monetary interests. Our monetary income goes back into research, development, discovery and healing.
Inspirational Technologies – is Committed to Your Health Wellness Beauty and EnrichmentReporting on Today’s Internal Botanical and Skin Product Benefits
4 Hemp Club was Inspired by Steven Smith’s vision to
“Have an older generation 4H Club, where an older community of adults could carry on what the younger 4H Club envisioned.
Our 4H Platform Uses HEMP as an Agricultural Focal Point, deserving of research, development and with the
4 Hemp key points being Health Hope and Happiness, thru Hemp“.
Cannabis CBD and Me Inspirational Technologies Inspirational Technologies (2014) @Inspire123tech Background Noise Studios Logos by Steven M Smith
1st Hemp USA News is a resource of Inspirational Technologies (2021-2022)Inspirational Technologies (2022) AllRightsReservedYour ONE STOP BLOG FOR INFORMATION, EDUCATION, & INSPIRATION OF ESSENTIAL INNOVATION & RENOVATION of You-THANK YOU FOR YOUR INTEREST*This site receives virtually no compensation for sales of some or all mentioned products. We however place humanitarian value over monetary interests. Our monetary income goes back into research, development, discovery and healing.Inspirational Technologies – is Committed to Your Health Wellness Beauty and EnrichmentReporting on Today’s Internal Botanical and Skin Product Benefits
4 Hemp Club was Inspired by Steven Smith’s vision to
“Have an older generation 4H Club, where an older community of adults could carry on what the younger 4H Club envisioned.
Our 4H Platform Uses HEMP as an Agricultural Focal Point, deserving of research, development and with the
4 Hemp key points being Health Hope and Happiness, thru Hemp“.
Cannabis CBD and Me Inspirational Technologies Inspirational Technologies (2014) @Inspire123tech Background Noise Studios Logos by Steven M Smith
You must be logged in to post a comment.